Home » Novo Nordisk Hikes 2026 Outlook Again

Novo Nordisk Hikes 2026 Outlook Again

November 4, 2026November 4, 2026

This post was originally published on this site.

The Ozempic maker raised its full-year outlook for the third time this year on Wednesday as its Wegovy pill beat third-quarter sales forecasts, boosting the Danish firm’s bid to win back ground from US rival Eli Lilly.

FlashNews:

How to turn pasta odds and ends into a winning bake – recipe | Waste not

Estée Lauder Sets 2030 Growth, Margin Targets as Turnaround Advances

Canton’s CC rises 4% as SEC staff view it as ‘digital commodity’

Nykaa Quarterly Profit Nearly Triples on Beauty Demand, Margin Gains

I Tried Amazon’s New Kindles. Buy This Accessory Instead (2026)

Binance hack may be ‘temporary setback’ for crypto, Grayscale’s Pandl says

Best Wireless Earbuds I’d Buy Right Now (2026): Apple, Beats, Bose, and More

Celebrity hairstylist John Frieda dies aged 75

Fleabag star offers rent-free flat to new writers

Report: CVS Plans to Break Up Healthcare Conglomerate

AGENT Unveils Coordinated Multi-Agent AI System and Sets December 1 Start for AGENT Token Community Presale

New Jersey’s New Ebike Law Is Causing Chaos

What’s the Difference Between an Ebike and an E-Moto?

Pandora Nudges Up Outlook, Speeds Up Launches

Qatar Airways Connects Doha to Caracas, Venezuela, and Bogotá, Colombia with First Flight

Novo Nordisk Hikes 2026 Outlook Again

Justin Sun seeks $264K sanctions over World Liberty’s UAE disclosure

Visit Brasil & Beautiful Destinations Launch Global Carnival Campaign at WTM London 2026

Shanghai Disney Resort Invites Guests into a World of Fairytale Enchantment

oneworld’s Seoul Incheon Lounge Named “Asia’s Leading Airline Lounge – Business Class” at WTA’s

Novo Nordisk Hikes 2026 Outlook Again